Evidence map›Paper›PMID 32638296›Full record

ArticleHepatology international2020

Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases.

Chihua Fang, Jihyun An, Antonio Bruno, Xiujun Cai, Jia Fan, Jiro Fujimoto, Rita Golfieri, Xishan Hao, Hongchi Jiang, Long R Jiao and 27 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Hepatology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 13 countries.

Chihua FangThe First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou, 510282, China. fangch_dr@163.com.
Jihyun AnDepartment of Gastroenterology, Hanyang University College of Medicine and Hanyang University Guri Hospital, Guri, 11923, South Korea.
Antonio BrunoDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Via Giuseppe Massarenti 9, 40138, Bologna, Italy.
Xiujun CaiDepartment of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Jia FanDepartment of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, 200032, China.
Jiro FujimotoDepartment of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Rita GolfieriDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Via Giuseppe Massarenti 9, 40138, Bologna, Italy.
Xishan HaoDepartment of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Hongchi JiangDepartment of Liver Surgery, The First Affiliated Hospital Harbin Medical University, Harbin, 150001, Heilongjiang, China.
Long R JiaoHPB Surgical Unit, Department of Surgery and Cancer, Imperial College, London, W12 0HS, UK.
Anand V KulkarniDepartment of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
Hauke LangDepartment of General, Visceral and Transplantation Surgery, University Medical Center of the Johannes Gutenberg-University, Langenbeckst. 1, 55131, Mainz, Germany.
Cosmas Rinaldi A LesmanaDivision of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, 10430, Indonesia.
Qiang LiNational Clinical Research Center for Cancer and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Lianxin LiuDepartment of Hepatobillirary Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, Anhui, China.
Yingbin LiuDepartment of General Surgery, Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wanyee LauFaculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Qiping LuDepartment of General Surgery, Central theater General Hospital of the Chinese people's Liberation Army, Wuhan, 430070, Hubei, China.
Kwan ManDepartment of Surgery, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Hitoshi MaruyamaDepartment of Gastroenterology, Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Cristina MosconiDepartment of Experimental, Diagnostic and Specialty Medicine-DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Via Giuseppe Massarenti 9, 40138, Bologna, Italy.
Necati ÖrmeciDepartment of Gastroenterology, Ankara University Medical School, Ibn'i Sina Hospital, Sihhiye, 06100, Ankara, Turkey.
Michael PavlidesOxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Guilherme RezendeInternal Medicine Department, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Joo Hyun SohnDepartment of Gastroenterology, Hanyang University College of Medicine and Hanyang University Guri Hospital, Guri, 11923, South Korea.
Sombat TreeprasertsukDivision of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, 10700, Thailand.
Valérie VilgrainDepartment of Radiology, Assistance-Publique Hôpitaux de Paris, APHP, HUPNVS, Hôpital Beaujon, 100 bd du Général Leclerc, 92110, Clichy, France.
Hao WenDepartment of Hydatid & Hepatobiliary Surgery, Digestive and Vascular Surgery Centre, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Sai WenThe First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou, 510282, China.
Xianyao QuanDepartment of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China.
Rafael XimenesDepartment of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.
Yinmo YangDepartment of General Surgery, Peking University First Hospital, Beijing, China.
Bixiang ZhangDepartment of Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Weiqi ZhangThe First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou, 510282, China.
Peng ZhangThe First Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangdong Provincial Clinical and Engineering Center of Digital Medicine, Guangzhou, 510282, China.
Shaoxiang ZhangInstitute of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Xiaolong QiCHESS Center, Institute of Portal Hypertension, The First Hospital of Lanzhou University, Lanzhou, China. qixiaolong@vip.163.com.
Southern Medical University · CNHanyang University Guri Hospital · KRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITTianjin Medical University Cancer Institute and Hospital · CNAnkara University · TRArmy Medical University · CNAsian Institute of Gastroenterology · INChinese University of Hong Kong · HKFirst Affiliated Hospital of Harbin Medical University · CNFirst Hospital of Lanzhou University · CNHôpital Beaujon · FRHyogo Medical University · JPImperial College London · GBJohannes Gutenberg University Mainz · DEJuntendo University · JPKing Chulalongkorn Memorial Hospital · THPeking University First Hospital · CNShanghai Jiao Tong University · CNTongji Hospital · CNUniversidade de São Paulo · BR

Funding

National High-tech R&D Program of China (863 program) 2006AA022346National High-tech R&D Program of China (863 program) 2012AA021105National Key R&D Program 2016YFC0106500National Major Scientific Research Instrument Development Project 81627805National Natural Science Foundation of China 81600510NSFC-GD Union Foundation U1401254
6 · The paper itself

Abstract

Three-dimensional (3D) visualization involves feature extraction and 3D reconstruction of CT images using a computer processing technology. It is a tool for displaying, describing, and interpreting 3D anatomy and morphological features of organs, thus providing intuitive, stereoscopic, and accurate methods for clinical decision-making. It has played an increasingly significant role in the diagnosis and management of liver diseases. Over the last decade, it has been proven safe and effective to use 3D simulation software for pre-hepatectomy assessment, virtual hepatectomy, and measurement of liver volumes in blood flow areas of the portal vein; meanwhile, the use of 3D models in combination with hydrodynamic analysis has become a novel non-invasive method for diagnosis and detection of portal hypertension. We herein describe the progress of research on 3D visualization, its workflow, current situation, challenges, opportunities, and its capacity to improve clinical decision-making, emphasizing its utility for patients with liver diseases. Current advances in modern imaging technologies have promised a further increase in diagnostic efficacy of liver diseases. For example, complex internal anatomy of the liver and detailed morphological features of liver lesions can be reflected from CT-based 3D models. A meta-analysis reported that the application of 3D visualization technology in the diagnosis and management of primary hepatocellular carcinoma has significant or extremely significant differences over the control group in terms of intraoperative blood loss, postoperative complications, recovery of postoperative liver function, operation time, hospitalization time, and tumor recurrence on short-term follow-up. However, the acquisition of high-quality CT images and the use of these images for 3D visualization processing lack a unified standard, quality control system, and homogeneity, which might hinder the evaluation of application efficacy in different clinical centers, causing enormous inconvenience to clinical practice and scientific research. Therefore, rigorous operating guidelines and quality control systems need to be established for 3D visualization of liver to develop it to become a mature technology. Herein, we provide recommendations for the research on diagnosis and management of 3D visualization in liver diseases to meet this urgent need in this research field.

Indexed as

Imaging, Three-DimensionalLiver DiseasesTomography, X-Ray ComputedHumansComputed tomographyConsensusHepatocellular carcinomaHepatolithiasisHilar cholangiocarcinomaLiving donor liver transplantationPortal hypertensionQuality control systemThree-dimensional printingThree-dimensional visualization

Identifiers

PMID32638296
PMCPMC7366600
OpenAlexW3041749931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.